Lars Nieba | Chief Executive Officer
Engimmune Therapeutics
Lars is CEO of Engimmune Therapeutics since April 2023. Before that he was CTO and CEO at Nordic Nanovector, a biotech company developing novel radio-immunoconjugates for treating cancers. Previously, Lars was VP and Strategic Product Lead at Bayer. Before that he held several leadership roles at F. Hoffmann-La Roche in clinical operations, clinical supply planning, biologics technology and business development. Lars gained his PhD from the Max-Planck-Institute for Biochemistry, Munich, and Institute for Biochemistry at the University of Zurich; he also holds an executive MBA from the University of St. Gallen, Switzerland.
Appearances:
BioTechX Europe Day 2 @ 14:30
Coupling protein engineering and AI to develop soluble multi-specific TCR therapies
Get involved at BioTechX
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events